Arkolith/Insider Trading/ZBIO/Form 4

Moulder Leon O JR

Chief Executive Officer, DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4 · filed Sep 20, 2024
Net Buying
Open-Market Buys
$361K
Open-Market Sells
$0
Net Open-Market Flow
$361K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2024Buy(P)3K$18.97$50K1.7M
Sep 20, 2024Buy(P)2K$17.88$42K1.7M
Sep 19, 2024Buy(P)5K$17.89$89K1.7M
Sep 18, 2024Buy(P)10K$17.91$179K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-101773) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML